Aspen Pharmacare Pre-Tax Profit Margin 2017-2024 | APNHY

Aspen Pharmacare pre-tax profit margin from 2017 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Aspen Pharmacare Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $2.392B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.477B 5.66
Dr Reddy's Laboratories (RDY) India $11.411B 21.77
BridgeBio Pharma (BBIO) United States $6.430B 0.00
Bausch Health Cos (BHC) Canada $1.876B 1.36
Supernus Pharmaceuticals (SUPN) United States $1.717B 16.02
Amphastar Pharmaceuticals (AMPH) United States $1.109B 6.71
Personalis (PSNL) United States $0.282B 0.00
Taysha Gene Therapies (TSHA) United States $0.254B 0.00
Assembly Biosciences (ASMB) United States $0.075B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.003B 0.00
Teligent (TLGT) United States $0.000B 0.00